mAbDx and Peace Health Laboratories sign agreement for a collaborative clinical study to evaluate utility of sepsis biomarkers monitored with non-invasive sampling.
read morePeaceHealth Institutional Review Board (IRB) Approves mAbDx Clinical Study of Sepsis
PeaceHealth Institutional Review Board (IRB) approves a mAbDx clinical study to evaluate utility of sepsis biomarkers monitored with non-invasive sampling.
read moreEUROMIT 8 Research Report by CSO Michael Marusich: Non-invasive cheek swab sampling reveals mitochondrial dysfunction associated with HIV/AIDS antiretroviral therapy
Research presentation by mAbDx CSO Michael Marusich at EUROMIT 8, The Eighth European Meeting on Mitochondrial Pathology “From mitochondrial diseases to mitochondria in health and disease”, Zaragoza, Spain. Title: “OXPHOS Levels in Cheek Swabs Reveal Mitochondrial Dysfunction Associated with HIV/AIDS and/or Antiretroviral Therapy (ART).”
read moreCSO Michael Marusich reports on mitochondrial DAMPS at 2011 United Mitochondrial Disease Foundation International Conference
Research presentation by mAbDx CSO Michael Marusich at the “2011 United Mitochondrial Disease Foundation International Conference”, Schaumburg, Ill. Title: “Immunochemical/Proteomic identification of novel inflammatory mitochondrial peptides.”
read more